Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Stargardt Disease · Muscle Relaxation · ELTP

ELITE PHARMACEUTICALS INC

ELITE PHARMACEUTICALS INC /NV/

ELITE PHARMACEUTICALS INC patent portfolio — 26 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
Northvale, USA HQ
1996 Founded
64 Employees
Public company Type
ELTP · NYSE Ticker
Company details
Status
Public
HQ
Northvale, USA
Founded
1996
Employees
64
Programs
8
Drugs
24
Patents
26
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Patents

ELITE PHARMACEUTICALS INC patents

26 pharmaceutical patents indexed for ELITE PHARMACEUTICALS INC. 0 expire within 24 months.

ELITE PHARMACEUTICALS INC has 26 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

26 patents

Patent portfolio

  1. US 12364693

    Methods of treating metabolic diseases with fused bicyclic pyrazoles

    Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12295394

    Water-soluble additive composition

    Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12116596

    Method and apparatus for improved mesenchymal stem cell harvesting

    Expires Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12016853

    Methods of treating RBP4 related diseases with triazolopyridines

    Expires Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11951100

    Formulations of RBP4 inhibitors and methods of use

    Expires Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11723873

    Oral dosage form of ticagrelor and preparation method thereof

    Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11684596

    Antidiabetic pharmaceutical compositions and preparation method thereof

    Expires Mon Jun 22 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11655454

    Method and apparatus for improved mesenchymal stem cell harvesting

    Expires Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11389444

    Methods of treating metabolic diseases with fused bicyclic pyrazoles

    Expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11007186

    Methods of treating RBP4 related diseases with triazolopyridines

    Expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 10668021

    Metformin hydrochloride osmotic pump tablet and preparation method therefor

    Expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 10245259

    Methods of treating RBP4 related diseases with triazolopyridines

    Expires Mon Mar 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10213388

    Abuse resistant oral dosage forms

    Expires Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10149903

    Fully human antibody against respiratory syncytical virus

    Expires Mon Dec 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9346867

    Cancer-related glycopeptide epitopes, antibodies and methods of use

    Expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9334495

    Minor groove binder (MGB)-oligonucleotide miRNA antagonists

    Expires Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9125822

    Particle for medical use and process for producing the same

    Expires Mon Sep 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9056054

    Abuse resistant oral dosage forms

    Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8980855

    Minor groove binder (MGB)-oligonucleotide miRNA antagonists

    Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8703186

    Abuse-resistant oral dosage forms and method of use thereof

    Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8529257

    Aerosolized ceramic porcelains and glaze composition

    Expires Mon Sep 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8425933

    Abuse-resistant oral dosage forms and method of use thereof

    Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8182836

    Abuse-resistant oral dosage forms and method of use thereof

    Expires Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7018465

    Aerosolized ceramic porcelains and glaze composition

    Expires Mon Mar 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  25. US 6984402

    Chrono delivery formulations and method of treating atrial fibrillation

    Expires Mon Jan 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  26. US 6926909

    Chrono delivery formulations and method of use thereof

    Expires Mon Aug 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does ELITE PHARMACEUTICALS INC have?

26 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do ELITE PHARMACEUTICALS INC patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.